Product
PLX-R18
1 clinical trial
1 indication
Indication
Hematopoietic Cell TransplantationClinical trial
A Phase I Open-label Dose-escalation Study to Evaluate the Safety of Intramuscular Injections of PLX-R18 in Subjects With Incomplete Hematopoietic Recovery Following Hematopoietic Cell TransplantationStatus: Completed, Estimated PCD: 2021-09-30